Literature DB >> 4999067

Clinical uses and control of rifampicin and clindamycin.

I Phillips.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4999067      PMCID: PMC477019          DOI: 10.1136/jcp.24.5.410

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


× No keyword cloud information.
  40 in total

1.  Rifampicin: a new rifamycin. I. Bacteriological studies.

Authors:  V Arioli; R Pallanza; S Furesz; G Carniti
Journal:  Arzneimittelforschung       Date:  1967-05

2.  Laboratory and clinical evaluation of 7-chloro-7-deoxylincomycin.

Authors:  S Oppenheimer; M Turek
Journal:  Am J Med Sci       Date:  1968-11       Impact factor: 2.378

3.  Antibiotic inhibitors of the bacterial ribosome.

Authors:  B Weisblum; J Davies
Journal:  Bacteriol Rev       Date:  1968-12

4.  Clindamycin in the treatment of pyoderma.

Authors:  B Kanee
Journal:  Appl Ther       Date:  1969-09

5.  Structure-activity relationships of rifamycin derivatives.

Authors:  P Sensi
Journal:  Acta Tuberc Pneumol Belg       Date:  1969

6.  Absorption, excretion and half-life of clinimycin in normal adult males.

Authors:  J G Wagner; E Novak; N C Patel; C G Chidester; W L Lummis
Journal:  Am J Med Sci       Date:  1968-07       Impact factor: 2.378

7.  Group A streptococci resistant to clindamycin.

Authors:  J Kohn; A J Evans
Journal:  Br Med J       Date:  1970-05-16

8.  [Practical experiences with 7-chloro-7-desoxy-lincomycin in jaw surgery].

Authors:  D Schlegel; E Hieber
Journal:  Zahnarztl Prax       Date:  1969-02-15

9.  The antistaphylococcal activity of Rifampicin.

Authors:  M G Bals; S Filipescŭ
Journal:  Arzneimittelforschung       Date:  1969-08

10.  Hemodialysis properties of clindamycin (7-chloro-7-deoxylincomycin).

Authors:  J E Cimino; P M Tierno
Journal:  Appl Microbiol       Date:  1969-03
View more
  8 in total

1.  A studyof the pharmacokinetics of clidamycin in normal subjects and patients with chronic renal failure.

Authors:  J B Eastwood; P E Gower
Journal:  Postgrad Med J       Date:  1974-11       Impact factor: 2.401

2.  Failure of rifampin to inhibit adenovirus replication.

Authors:  D P McCormick; R P Wenzel; E P Smith; W E Beam
Journal:  Antimicrob Agents Chemother       Date:  1972-10       Impact factor: 5.191

3.  Chemotherapy of experimental streptococcal endocarditis. I. Comparison of commonly recommended prophylactic regimens.

Authors:  D T Durack; R G Petersdorf
Journal:  J Clin Invest       Date:  1973-03       Impact factor: 14.808

4.  New antibacterial drugs.

Authors: 
Journal:  Br Med J       Date:  1971-10-16

Review 5.  Rifamycin antibiotics and the mechanisms of their failure.

Authors:  Rebekah A Adams; Gabrielle Leon; Natalia M Miller; Saira P Reyes; Chantal H Thantrong; Alina M Thokkadam; Annabel S Lemma; Darshan M Sivaloganathan; Xuanqing Wan; Mark P Brynildsen
Journal:  J Antibiot (Tokyo)       Date:  2021-08-16       Impact factor: 2.649

Review 6.  Rifampin combination therapy for nonmycobacterial infections.

Authors:  Graeme N Forrest; Kimberly Tamura
Journal:  Clin Microbiol Rev       Date:  2010-01       Impact factor: 26.132

7.  Evaluation of human primary intestinal monolayers for drug metabolizing capabilities.

Authors:  Jennifer E Speer; Yuli Wang; John K Fallon; Philip C Smith; Nancy L Allbritton
Journal:  J Biol Eng       Date:  2019-11-04       Impact factor: 4.355

8.  Epidemiological Characteristics and Drug Resistance Analysis of Cerebrospinal Fluid Microbial Infections in Wenzhou Area.

Authors:  Teng Zhou; Mengjiao Kuang; Shirui Huang; Jizhen Li; Qipeng Xie
Journal:  Infect Drug Resist       Date:  2021-06-03       Impact factor: 4.003

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.